Skip to main content

People in the News: Sep 8, 2011

Premium

Marina Biotech has announced a number of organizational changes.

The company said that Richard Ho, previously senior medical director of Entelos, has joined Marina as executive vice president of research and development.

CFO Peter Garcia has resigned and will be replaced by Philip Ranker, formerly CFO of Suneva Medical.

Barry Polisky has stepped down as Marina's CSO and will become a distinguished scientist and chairman of the company's scientific advisory panel. Alan Dunton, who founded pharmaceutical consulting firm Danerius, has been hired as the company's new CSO.

Lastly, Michael Templin, Marina's senior vice president of preclinical development, has been promoted to senior vice president and CTO.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.